Earnings Per Share

INO Upcoming Earnings (Q4 2024)

Earnings Date: Mar 05, 2025
Consensus EPS: Premium

Current P/E ratio : -0.0046
Price (Dec 05, 2024, EOD): $4.02

The P/E ratio (price-to-earnings ratio) is a financial metric used to assess a company's stock valuation. It is calculated by dividing the stock price by its earnings per share. A higher ratio suggests higher investor expectations, while a lower ratio may indicate undervaluation. It helps investors evaluate potential investments, but it's essential to consider other factors too.

Last 3 Quarters for INO Premium

Below you can see how INO performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.

Earnings Report Demo

FAQ

When is the earnings report for INO?
Inovio Pharmaceuticals (INO) has scheduled its earnings report for Mar 05, 2025 after the markets close.

What is the INO price-to-earnings (P/E) ratio?
INO P/E ratio as of Dec 05, 2024 (TTM) is -0.0046.

What is the INO EPS forecast?
The forecasted EPS (Earnings Per Share) for Inovio Pharmaceuticals (INO) for the first fiscal quarter 2024 is -$0.98.

What are Inovio Pharmaceuticals's retained earnings?
On its balance sheet, Inovio Pharmaceuticals reported retained earnings of $0 for the latest quarter ending Sep 30, 2024.

What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.

Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.

What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
Click to get the best stock tips daily for free!
ABOUT INOVIO PHARMACEUTICALS
Inovio Pharmaceuticals
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery o...
GOLDEN STAR
Ticker Change Signal Date
SMAR
$56.02
0.196% Dec 03
G
GOF
$15.83
0.790% Dec 02
QSR
$69.61
0.165% Nov 29
HP
$34.63
0.462% Nov 29
B
BSCO
$21.11
0.0947% Nov 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE